Skip to main content
Skip to section navigation
Skip to footer
Investors & Media
Overview
News & Events
Company Info
Financial Info
SEC Filings
Clinical Trials
Overview
IDEAL Trial for PBC
AFFIRM Trial for PBC
PBC with Hepatic Impairment
ASSURE Trial for PBC
RESPONSE Trial for PBC
Careers
Contact Us
Home
Our Company
Overview
Leadership Team
Our Purpose
Overview
About Liver Disease
About PBC
Patient Advocacy
Patient Resources
Grants & Giving
Expanded Access
Our Science
Overview
Unmet Needs in PBC
Seladelpar
Collaborations
Investors & Media
Clinical Trials
Careers
Contact Us
Financial Information
Investors & Media
Investors & Media
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Publications
Email Alerts
Company Info
Overview
Leadership Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Latest Financial Results
FY 2023
Fiscal Year Ended Dec 31, 2023
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Income Statement
Balance Sheet
Cash Flow
Email Alerts
Company Profile
Contacts
RSS News Feed
You are leaving our website!
Continue